Compile Data Set for Download or QSAR
Report error Found 15 Enz. Inhib. hit(s) with all data for entry = 50005101
TargetCathepsin S(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032805(N-[2-(3-Morpholin-4-yl-ureido)-1-naphthalen-2-ylme...)
Affinity DataKi:  1.80nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032803(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[3-methyl-1...)
Affinity DataKi:  5.90nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin S(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032802(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[1-benzyl-2...)
Affinity DataKi:  11nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin SMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032805(N-[2-(3-Morpholin-4-yl-ureido)-1-naphthalen-2-ylme...)
Affinity DataKi:  18nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCruzipain(Trypanosoma cruzi)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032805(N-[2-(3-Morpholin-4-yl-ureido)-1-naphthalen-2-ylme...)
Affinity DataKi:  48nMAssay Description:Compound is evaluated for inhibitory potency against CruzaineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032805(N-[2-(3-Morpholin-4-yl-ureido)-1-naphthalen-2-ylme...)
Affinity DataKi:  150nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCruzipain(Trypanosoma cruzi)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032803(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[3-methyl-1...)
Affinity DataKi:  220nMAssay Description:Compound is evaluated for inhibitory potency against CruzaineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032803(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[3-methyl-1...)
Affinity DataKi:  230nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin O2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032804(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[1-(4-hydro...)
Affinity DataKi:  340nMAssay Description:Compound is evaluated for inhibition kinetic constant Ki for the cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCruzipain(Trypanosoma cruzi)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032802(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[1-benzyl-2...)
Affinity DataKi:  360nMAssay Description:Compound is evaluated for inhibitory potency against CruzaineMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032803(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[3-methyl-1...)
Affinity DataKi:  720nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetProcathepsin L(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032802(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[1-benzyl-2...)
Affinity DataKi:  1.00E+3nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin LMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032802(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[1-benzyl-2...)
Affinity DataKi:  1.10E+4nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin K(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032802(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[1-benzyl-2...)
Affinity DataKi:  3.05E+4nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin O2More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetCathepsin B(Human)
Khepri Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50032803(2-((E)-2-Benzenesulfonyl-vinylamino)-N-[3-methyl-1...)
Affinity DataKi:  3.90E+4nMAssay Description:Compound is evaluated for inhibitory potency against cathepsin BMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed